Caisse DE Depot ET Placement DU Quebec increased its position in shares of Imperva, Inc. (NASDAQ:IMPV) by 171.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 475,000 shares of the software maker’s stock after buying an additional 300,000 shares during the period. Caisse DE Depot ET Placement DU Quebec owned 1.40% of Imperva worth $20,702,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the stock. SG Americas Securities LLC bought a new stake in Imperva in the 3rd quarter valued at $134,000. First Quadrant L P CA bought a new stake in Imperva in the 3rd quarter valued at $136,000. Ameritas Investment Partners Inc. boosted its holdings in Imperva by 18.7% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 2,940 shares of the software maker’s stock valued at $141,000 after purchasing an additional 464 shares during the period. Migdal Insurance & Financial Holdings Ltd. boosted its holdings in Imperva by 26.2% in the 2nd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 4,177 shares of the software maker’s stock valued at $201,000 after purchasing an additional 866 shares during the period. Finally, Amalgamated Bank bought a new stake in Imperva in the 2nd quarter valued at $206,000. 96.95% of the stock is owned by institutional investors and hedge funds.
A number of analysts have weighed in on the stock. BidaskClub raised shares of Imperva from a “sell” rating to a “hold” rating in a report on Tuesday, September 12th. Imperial Capital reduced their price target on shares of Imperva from $57.00 to $50.00 and set an “outperform” rating for the company in a report on Tuesday, October 10th. William Blair downgraded shares of Imperva from an “outperform” rating to a “market perform” rating in a report on Tuesday, October 10th. Wells Fargo & Company cut shares of Imperva from an “outperform” rating to a “market perform” rating in a research note on Monday, October 9th. Finally, Evercore ISI set a $56.00 price objective on shares of Imperva and gave the company a “buy” rating in a research note on Thursday, August 10th. Two equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating, nine have issued a buy rating and one has given a strong buy rating to the stock. Imperva currently has an average rating of “Hold” and a consensus price target of $52.38.
Imperva (NASDAQ:IMPV) last announced its quarterly earnings data on Wednesday, November 8th. The software maker reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.22 by $0.11. Imperva had a net margin of 3.04% and a negative return on equity of 8.52%. The company had revenue of $83.89 million during the quarter, compared to analysts’ expectations of $83.79 million. During the same quarter in the prior year, the company posted $0.08 EPS. The business’s revenue was up 22.6% on a year-over-year basis. sell-side analysts forecast that Imperva, Inc. will post -0.52 earnings per share for the current fiscal year.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva, Inc. (NASDAQ:IMPV).
Receive News & Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related companies with MarketBeat.com's FREE daily email newsletter.